TGFβ2 in embryos with inborn anomalies: Effect of maternal immunopotentiation

American Journal of Reproductive Immunology

Volumn 45, Issue 1, 2001, Pages 41-51

  Ivnitsky, Irena ^a   Torchinsky, Arkady ^a   Savion, Shoshana ^a   Shepshelovich, Jeanne ^a   Orenstein, Hasida ^a   Toder, Vladimir ^a   Fein, Amos ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Embryo; Immunopotentiation; Teratogenesis; TGF 2

Indexed keywords

MESSENGER RNA; TERATOGENIC AGENT; TRANSFORMING GROWTH FACTOR BETA2; CYCLOPHOSPHAMIDE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIRTH DEFECT; BRAIN; CONTROLLED STUDY; DEFORMITY; EMBRYO; EMBRYOTOXICITY; FACE; GENE EXPRESSION; IMMUNE SYSTEM; IMMUNOPOTENTIATION; LIMB; LIVER; MATERNAL TREATMENT; MICROGNATHIA; MOUSE; NONHUMAN; PHOCOMELIA; PRIORITY JOURNAL; PROTECTION; TERATOGENESIS; ADOPTIVE TRANSFER; ANIMAL; APOPTOSIS; CONGENITAL MALFORMATION; GENETICS; INSTITUTE FOR CANCER RESEARCH MOUSE; LONG EVANS RAT; MALE; METABOLISM; PHYSIOLOGY; RAT; XENOGRAFT;

ABNORMALITIES, DRUG-INDUCED; ADOPTIVE TRANSFER; ANIMALS; APOPTOSIS; CYCLOPHOSPHAMIDE; MALE; MICE; MICE, INBRED ICR; RATS; RATS, LONG-EVANS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, HETEROLOGOUS;

EID: 0034746415     PISSN: 87558920     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.8755-8920.2001.450107.x     Document Type: Article

References (10)

1. Pepper MS: Transforming growth factor-beta: Vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 1997; 8:21-43.
2. Taipale J, Keski-Oja J: Growth factors in the extracellular matrix. FASEB J 1997; 11:51-59.
3. Rosfjord EC, Dickson RB: Growth factors, apoptosis, and survival of mammary epithelial cells. J Mammary Gland Biol Neoplasia 1999; 4:229-237.
4. Bonewald LF: Regulation and regulatory activities of transforming growth factor beta. Crit Rev Eukaryot Gene Exp 1999; 9:33-44.
5. Millan FA, Denhez F, Kondaiah P, Akhurst RJ: Embryonic gene expression patterns of TGF beta 1, beta 2 and beta 3 suggest different developmental functions in vivo. Development 1991; 111:131-143.
6. Lea RG, Underwood J, Flanders KC, Hirte H, Banwatt D, Finotto S, Ohno I, Daya S, Harley C, Michel M, Mowbray JF, Clark DA: A subset of patients with recurrent spontaneous abortion is deficient in transforming growth factor beta-2-producing "suppressor cells" in uterine tissue near the placental attachment site. Am J Reprod Immunol 1995; 34:52-64.
7. Godkin JD, Dore JJ: Transforming growth factor beta and the endometrium. Rev Reprod 1998; 3:1-6.
8. Clark DA, Arck PC, Chaouat G: Why did your mother reject you? Immunogenetic determinants of the response to environmental selective pressure expressed at the uterine level. Am J Reprod Immunol 1999; 41:5-22.
9. Sanford LP, Ormsby I, Gittenberger-de Groot AC, Sariola H, Friedman R, Boivin GP, Cardell EL, Doetschman T: TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development 1997; 124:2659-2670.
10. Kaartinen V, Voncken JW, Shuler C, Warburton D, Bu D, Heisterkamp N, Groffen J: Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nat Genet 1995; 11:415-421.